サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1373935

バイオエンジニアリングタンパク質医薬品市場：医薬品タイプ別、疾患別、技術別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2023～2030年）

Bioengineered Protein Drugs Market, by Drugs Type, by Diseases, by Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 289 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
バイオエンジニアリングタンパク質医薬品市場：医薬品タイプ別、疾患別、技術別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2023～2030年）
出版日: 2023年10月01日
発行: AnalystView Market Insights
ページ情報: 英文 289 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオエンジニアリングタンパク質医薬品の市場規模は、2022年に3,541億22万米ドルとなり、2023年から2030年にかけてCAGRで8.01％の成長が予測されています。

これらの治療薬は、特定の生物学的プロセスを標的とする精度の高さ、副作用を最小限に抑える可能性、患者の健康と全体的な幸福を改善する有望性により、医療分野で重要な位置を占めています。

バイオエンジニアリングタンパク質医薬品市場 - 市場力学

複雑で治療が課題となっている疾患の蔓延が市場の需要を促進

バイオエンジニアリング・タンパク質由来の医薬品に対する需要は、複雑で治療が困難な疾患の有病率の増加によって大きく促進されています。自己免疫疾患、がん、希少遺伝病などの疾患では、高度に的を絞った個別化治療が必要とされることが多いです。酵素の代替品やモノクローナル抗体などのバイオ工学的タンパク質治療薬は、これらの疾患を管理するための精密で強力なソリューションの一例です。

さらに、バイオテクノロジーと遺伝子工学の進歩により、これらの治療薬をより効率的に生産することが可能になり、生産コストの削減と入手しやすさの向上につながっています。その結果、疾患の根本的な原因に対する理解が深まり、オーダーメイドの治療が期待できるようになったことに加え、患者の転帰と生活の質を高める可能性があることから、バイオエンジニアリングタンパク質医薬品に対する需要が高まっています。

バイオエンジニアリングタンパク質医薬品市場 - 主要インサイト

弊社の調査アナリストによる分析によると、バイオエンジニアリングタンパク質医薬品の世界市場は、2023年から2030年までの予測期間において約8.01%の年間成長率を記録する見込みです。

バイオエンジニアリングタンパク質医薬品業界は、主に複雑で治療が困難な疾病の蔓延が増加していることを背景に、大きな成長が見込まれています。

医薬品タイプ別セグメンテーションでは、2022年は治療用酵素が市場をリードするカテゴリーとなっています。

疾患別では、糖尿病が2022年の主要セグメントとして浮上しました。

技術別では、2022年にファーミングが主要カテゴリーとなっています。

最後に、地域に関しては、北米が2022年の主要収益源として際立っていました。

バイオエンジニアリングタンパク質医薬品市場 - セグメンテーション分析：

バイオエンジニアリングタンパク質医薬品の世界市場は、医薬品タイプ、疾患、技術、地域によって区分されます。

医薬品タイプでは、ペプチドホルモン、組換えタンパク質医薬品、治療用酵素、ワクチン、サイトカイン、モノクローナル抗体、ペプチド抗生物質、代替タンパク質、その他を含む幅広いカテゴリーが含まれます。特に、治療用酵素は、様々な病状の治療に汎用性があり、個別化医療に応用できる可能性があることから、バイオエンジニアリングタンパク質医薬品業界をリードすると予想されています。

バイオエンジニアリングタンパク質医薬品市場 - 地理的洞察

この市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカなど、さまざまな地理的地域にまたがっています。これらの地域は、市場に貢献している国によってさらに細分化されます。

北米が市場を独占すると予想されるが、その主な理由は、バイオエンジニアリング蛋白質治療薬の分野における著しい技術進歩や広範な研究開発への取り組みが、業界における主導的地位に貢献しているためです。

バイオエンジニアリングタンパク質医薬品市場 - 競合情勢：

各社は、企業ウェブサイト、eコマース・プラットフォーム、小売店、流通パートナー、消費者への直接販売など、さまざまなチャネルを通じて製品を販売しています。これらの製品メーカーは、価格、製品性能、製造能力、流通チャネル、ブランドの評判、製品の入手可能性など、さまざまな側面で競合関係にあります。

市場での存在感を高め、市場シェアを拡大するために、企業は様々な戦略を採用しています。これらの戦略には、新製品の発売、流通網の拡大、研究開発への投資、M&Aなどが含まれます。一例として、2022年4月、サテライト・バイオは組織工学への革新的なアプローチを発表しました。同社は再生医療、合成生物学、細胞生物学、細胞療法、組織工学を専門としています。

目次

第1章 バイオエンジニアリングタンパク質医薬品市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 バイオエンジニアリングタンパク質医薬品の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 バイオエンジニアリングタンパク質医薬品産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 バイオエンジニアリングタンパク質医薬品市場：COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 バイオエンジニアリングタンパク質医薬品市場情勢

  • バイオエンジニアリングタンパク質医薬品市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 バイオエンジニアリングタンパク質医薬品市場 - 医薬品タイプ別

  • 概要
    • 医薬品タイプ別セグメントシェア分析
    • ペプチドホルモン
    • 組換えタンパク質医薬品
    • 治療用酵素
    • ワクチン
    • サイトカイン
    • モノクローナル抗体
    • ペプチド抗生物質
    • 代替タンパク質
    • その他

第8章 バイオエンジニアリングタンパク質医薬品市場 - 疾患別

  • 概要
    • 疾患別セグメントシェア分析
    • がん
    • 糖尿病
    • 血液疾患
    • 皮膚疾患
    • 神経変性疾患
    • 心疾患
    • 感染症
    • 呼吸器疾患
    • その他

第9章 バイオエンジニアリングタンパク質医薬品市場 - 技術別

  • 概要
    • セグメントシェア分析（技術別）
    • バイオリアクター・微生物細胞発酵
    • 分別
    • 遺伝子組み換え生物
    • 遺伝子工学
    • ファーミング
    • その他

第10章 バイオエンジニアリングタンパク質医薬品市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - バイオエンジニアリングタンパク質医薬品産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Vertex Pharmaceuticals
    • Sanofi
    • Regeneron Pharmaceuticals
    • Pfizer
    • Novo Nordisk
    • Merck &Co.
    • Johnson &Johnson（Janssen Pharmaceuticals）
    • Gilead Sciences
    • Genentech（Roche）
    • Eli Lilly and Company
    • Bristol-Myers Squibb
    • Biogen
    • AstraZeneca
    • Amgen
    • AbbVie

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bioengineered Protein Drugs Market: Drug Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global Bioengineered Protein Drugs Market, by Drug Type 2018-2030 (USD Million)
  • TABLE Bioengineered Protein Drugs Market: Diseases Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Diseases
  • TABLE Global Bioengineered Protein Drugs Market, by Diseases 2018-2030 (USD Million)
  • TABLE Bioengineered Protein Drugs Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Bioengineered Protein Drugs Market, by Technology 2018-2030 (USD Million)
  • TABLE Bioengineered Protein Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bioengineered Protein Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE North America Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
  • TABLE North America Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Europe Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Europe Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Latin America Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Latin America Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)

List of Figures

  • FIGURE Bioengineered Protein Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Type segment market share analysis, 2022 & 2030
  • FIGURE Drug Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Diseases segment market share analysis, 2022 & 2030
  • FIGURE Diseases segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Bioengineered Protein Drugs Market share and leading players, 2022
  • FIGURE Europe Bioengineered Protein Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Bioengineered Protein Drugs Market share and leading players, 2022
  • FIGURE Latin America Bioengineered Protein Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Bioengineered Protein Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Bioengineered Protein Drugs Market share analysis by country, 2022
  • FIGURE Germany Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Bioengineered Protein Drugs Market share analysis by country, 2022
  • FIGURE India Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Bioengineered Protein Drugs Market share analysis by country, 2022
  • FIGURE Brazil Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Bioengineered Protein Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1810

REPORT HIGHLIGHT

Bioengineered Protein Drugs Market size was valued at USD 3,54,100.22 Million in 2022, expanding at a CAGR of 8.01% from 2023 to 2030.

Bioengineered protein therapeutics encompass medically valuable compounds generated through genetic engineering methodologies, often leveraging living organisms such as mammalian cells or bacteria to produce proteins with distinct therapeutic attributes. These medications emulate or enhance the functions of naturally occurring proteins within the body and are employed for the treatment of various medical conditions, including diabetes, cancer, and autoimmune disorders.

These therapeutics hold a significant place in the field of medicine due to their precision in targeting specific biological processes, their potential to minimize adverse effects, and their promise in improving the health and overall well-being of patients.

Bioengineered Protein Drugs Market- Market Dynamics

Increasing prevalence of complex and challenging-to-treat diseases to propel market demand

The demand for medications derived from bioengineered proteins is significantly propelled by the increasing prevalence of complex and challenging-to-treat diseases. Conditions such as autoimmune disorders, cancer, and rare genetic ailments often necessitate highly targeted and personalized treatments. Bioengineered protein therapeutics, such as enzyme replacements and monoclonal antibodies, exemplify precise and potent solutions for managing these disorders.

Furthermore, advancements in biotechnology and genetic engineering have made it possible to produce these therapeutics more efficiently, leading to reduced production costs and improved accessibility. Consequently, there is a growing demand for bioengineered protein therapeutics owing to their potential to enhance patient outcomes and quality of life, coupled with an enhanced understanding of the underlying causes of diseases and the promise of tailored treatments.

Bioengineered Protein Drugs Market- Key Insights

According to the analysis provided by our research analyst, the global market for Bioengineered Protein Drugs is expected to witness an annual growth rate of approximately 8.01% over the forecast period spanning from 2023 to 2030.

The Bioengineered Protein Drugs industry is poised for significant growth, primarily driven by the increasing prevalence of complex and challenging-to-treat diseases.

In terms of drug type segmentation, the year 2022 saw Therapeutic enzymes as the leading category in the market.

Regarding disease segmentation, Diabetes emerged as the dominant segment in 2022.

In terms of technology segmentation, Pharming was the leading category in 2022.

Finally, with respect to regions, North America stood out as the leading revenue generator in 2022.

Bioengineered Protein Drugs Market- Segmentation Analysis:

The Global Bioengineered Protein Drugs Market is segmented based on Drug Type, Disease, Technology, and Region.

In terms of Drug Type, the market encompasses a range of categories including Peptide hormones, Recombinant protein drugs, Therapeutic enzymes, Vaccines, Cytokines, Monoclonal antibodies, Peptide antibiotics, Replacement proteins, and Others. Notably, therapeutic enzymes are expected to lead the bioengineered protein drug industry due to their versatility in treating various medical conditions and their potential applicability in personalized medicine.

Bioengineered Protein Drugs Market- Geographical Insights

This market spans across various geographical regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented according to the countries contributing to the market.

North America is anticipated to dominate the market, primarily due to significant technological advancements and extensive research and development efforts in the field of bioengineered protein therapeutics, which have contributed to its leadership position in the industry.

Bioengineered Protein Drugs Market- Competitive Landscape:

Companies distribute their products through a variety of channels, which encompass corporate websites, e-commerce platforms, retail outlets, distribution partners, and direct-to-consumer sales. These product manufacturers engage in competition across several dimensions, including pricing, product performance, manufacturing capabilities, distribution channels, brand reputation, and product availability.

To enhance their market presence and expand their market share, businesses employ various strategies. These strategies encompass launching new products, expanding their distribution networks, investing in research and development, and engaging in mergers and acquisitions. As an example, in April 2022, Satellite Bio introduced an innovative approach to tissue engineering. This company specializes in regenerative medicine, synthetic biology, cell biology, cell therapy, and tissue engineering.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET KEY PLAYERS

  • Vertex Pharmaceuticals
  • Sanofi
  • Regeneron Pharmaceuticals
  • Pfizer
  • Novo Nordisk
  • Merck & Co.
  • Johnson & Johnson (Janssen Pharmaceuticals)
  • Gilead Sciences
  • Genentech (Roche)
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • Biogen
  • AstraZeneca
  • Amgen
  • AbbVie

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY DRUG TYPE

  • Peptide hormones
  • Recombinant protein drugs
  • Therapeutic enzymes
  • Vaccines
  • Cytokines
  • Monoclonal antibodies
  • Peptide antibiotics
  • Replacement proteins
  • Others

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY DISEASES

  • Cancer
  • Diabetes
  • Blood disorders
  • Skin diseases
  • Neurodegenerative diseases
  • Heart diseases
  • Infectious diseases
  • Respiratory diseases
  • Others

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY TECHNOLOGY

  • Bioreactors and Microbial Cell Fermentation
  • Fractionation
  • Genetically Modified Organisms
  • Genetic Engineering
  • Pharming
  • Others

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bioengineered Protein Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bioengineered Protein Drugs Market Snippet by Drug Type
    • 2.1.2. Bioengineered Protein Drugs Market Snippet by Diseases
    • 2.1.3. Bioengineered Protein Drugs Market Snippet by Technology
    • 2.1.4. Bioengineered Protein Drugs Market Snippet by Country
    • 2.1.5. Bioengineered Protein Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Bioengineered Protein Drugs Key Market Trends

  • 3.1. Bioengineered Protein Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bioengineered Protein Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bioengineered Protein Drugs Market Opportunities
  • 3.4. Bioengineered Protein Drugs Market Future Trends

4. Bioengineered Protein Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bioengineered Protein Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Bioengineered Protein Drugs Market Landscape

  • 6.1. Bioengineered Protein Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bioengineered Protein Drugs Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
    • 7.1.2. Peptide hormones
    • 7.1.3. Recombinant protein drugs
    • 7.1.4. Therapeutic enzymes
    • 7.1.5. Vaccines
    • 7.1.6. Cytokines
    • 7.1.7. Monoclonal antibodies
    • 7.1.8. Peptide antibiotics
    • 7.1.9. Replacement proteins
    • 7.1.10. Others

8. Bioengineered Protein Drugs Market - By Diseases

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diseases, 2022 & 2030 (%)
    • 8.1.2. Cancer
    • 8.1.3. Diabetes
    • 8.1.4. Blood disorders
    • 8.1.5. Skin diseases
    • 8.1.6. Neurodegenerative diseases
    • 8.1.7. Heart diseases
    • 8.1.8. Infectious diseases
    • 8.1.9. Respiratory diseases
    • 8.1.10. Others

9. Bioengineered Protein Drugs Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 9.1.2. Bioreactors and Microbial Cell Fermentation
    • 9.1.3. Fractionation
    • 9.1.4. Genetically Modified Organisms
    • 9.1.5. Genetic Engineering
    • 9.1.6. Pharming
    • 9.1.7. Others

10. Bioengineered Protein Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Bioengineered Protein Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Bioengineered Protein Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Bioengineered Protein Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Bioengineered Protein Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Bioengineered Protein Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Bioengineered Protein Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Vertex Pharmaceuticals
    • 11.2.2. Sanofi
    • 11.2.3. Regeneron Pharmaceuticals
    • 11.2.4. Pfizer
    • 11.2.5. Novo Nordisk
    • 11.2.6. Merck & Co.
    • 11.2.7. Johnson & Johnson (Janssen Pharmaceuticals)
    • 11.2.8. Gilead Sciences
    • 11.2.9. Genentech (Roche)
    • 11.2.10. Eli Lilly and Company
    • 11.2.11. Bristol-Myers Squibb
    • 11.2.12. Biogen
    • 11.2.13. AstraZeneca
    • 11.2.14. Amgen
    • 11.2.15. AbbVie

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us